CUSIP: 817763105
Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,944,093
-
Share change
-
+1,737,374
-
Total reported value
-
$10,035,000
-
Put/Call ratio
-
88%
-
Price per share
-
$0.72
-
Number of holders
-
35
-
Value change
-
+$1,257,644
-
Number of buys
-
18
-
Number of sells
-
9
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2020
-
Previous quarter:
Q1 2020
Recent filing periods for CUSIP 817763105:
Institutional Holders of SESEN BIO INC - COM (SESN) as of Q2 2020
As of 30 Jun 2020,
SESEN BIO INC - COM (SESN) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,944,093 shares.
The largest 10 holders included
VANGUARD GROUP INC, Eversept Partners, LP, BlackRock Inc., KINGDON CAPITAL MANAGEMENT, L.L.C., RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Stratos Wealth Partners, LTD., and GSA CAPITAL PARTNERS LLP.
This page lists
35
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.